首页> 外文期刊>Journal of Pathology: Journal of the Pathological Society of Great Britain and Ireland >Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.
【24h】

Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.

机译:在宫颈癌发生过程中通过启动子甲基化抑制MAL肿瘤抑制活性。

获取原文
获取原文并翻译 | 示例
           

摘要

We recently identified MAL (T-lymphocyte maturation associated protein) as the most down-regulated gene in cervical oncogenesis. Here, we examined the mechanism underlying MAL silencing, its functional role in cervical carcinogenesis, and the relevance of detecting MAL alterations for risk assessment of hrHPV-positive women. MAL mRNA expression and promoter methylation were analysed in primary keratinocytes, hrHPV-immortalized keratinocytes, cervical cancer cell lines, biopsies, and scrapings by quantitative (methylation-specific) PCR. SiHa cells were transfected with MAL cDNA and assayed for proliferation, migration, and anchorage-independent growth. MAL mRNA was (nearly) undetectable in all HPV-immortalized and cervical cancer cells, but could be up-regulated upon methylation inhibition. MAL promoter methylation at two promoter regions (M1 and M2) was detected in all HPV-immortalized cells and cancer cells. Ectopic expression of MAL in SiHa cells suppressed proliferation, migration, and anchorage-independent growth. None (0/22) of normal cervical biopsies, 9% (6/66) of CIN1 lesions, 53% (34/64) of CIN3 lesions, 90% (85/94) of cervical squamous cell carcinomas (SCCs), and 93% (26/28) of cervical adenocarcinomas (AdCAs) demonstrated MAL promoter methylation at both promoter regions. Moreover, detection of MAL promoter methylation in cervical scrapings was predictive for underlying high-grade lesions. Both in biopsies and in scrapings, MAL promoter methylation was significantly correlated with reduced mRNA expression. MAL gene silencing by promoter methylation is a frequent and biologically essential event in HPV-induced cervical carcinogenesis. Hence, MAL promoter methylation and/or mRNA expression analysis on cervical scrapings may provide a valuable diagnostic tool to improve the detection of CIN3, SCC, and AdCA.
机译:我们最近确定MAL(T淋巴细胞成熟相关蛋白)为宫颈癌发生过程中最下调的基因。在这里,我们研究了MAL沉默的潜在机制,其在宫颈癌变中的功能作用以及检测MAL改变对hrHPV阳性女性风险评估的相关性。通过定量(甲基化特异性)PCR分析了原代角质形成细胞,hrHPV永生化角质形成细胞,宫颈癌细胞系,活检和刮取物中的MAL mRNA表达和启动子甲基化。用MAL cDNA转染SiHa细胞,并检测其增殖,迁移和锚定非依赖性生长。在几乎所有的HPV永生化和宫颈癌细胞中均未检测到MAL mRNA,但在甲基化抑制后可能会上调。在所有HPV永生化细胞和癌细胞中,在两个启动子区域(M1和M2)检测到MAL启动子甲基化。 MAL在SiHa细胞中异位表达抑制增殖,迁移和锚定非依赖性生长。正常宫颈活检无(0/22),CIN1病变为9%(6/66),CIN3病变为53%(34/64),宫颈鳞状细胞癌(SCC)为90%(85/94)和93%(26/28)的宫颈腺癌(AdCAs)在两个启动子区域均显示MAL启动子甲基化。此外,在宫颈刮屑中检测到MAL启动子甲基化可预测潜在的高级病变。在活组织检查和刮取中,MAL启动子甲基化均与mRNA表达降低显着相关。通过启动子甲基化使MAL基因沉默是HPV诱导子宫颈癌发生中的常见且生物学必不可少的事件。因此,宫颈刮片上的MAL启动子甲基化和/或mRNA表达分析可提供有价值的诊断工具,以改善对CIN3,SCC和AdCA的检测。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号